Novo Nordisk Board Takeover: Wegovy's US Turnaround?

Novo Nordisk in crisis? The company's biggest investor just seized control of the board after disappointing Wegovy sales and a stock price crash. Find out why the Novo Nordisk Foundation wants to shake things up, install a new board, and refocus on the crucial US market to beat rivals like Eli Lilly. Is this a bold move or a step backward?The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.